MyFinsight
Home
About
Contact
Back
Income Statement
Citius Pharmaceuticals, Inc. (CTXR)
source: myfinsight.com
Download
Download image
Net loss applicable
to common...
-$8,789,872
(19.32%↑ Y/Y)
Net loss
attributable to...
-$414,000
Net loss
-$9,203,872
Loss before income
taxes
-$8,939,632
(14.28%↑ Y/Y)
Income tax expense
$264,240
(83.50%↑ Y/Y)
Total other income
(expense)
-$151,625
(-174.02%↓ Y/Y)
Operating loss
-$8,788,007
(17.36%↑ Y/Y)
Interest income
$20,637
(-89.93%↓ Y/Y)
Interest expense
$172,262
Total operating
expenses
$8,788,007
(-17.36%↓ Y/Y)
General and
administrative
$4,447,008
(-7.52%↓ Y/Y)
Research and development
$1,621,325
(-41.34%↓ Y/Y)
Stock-based compensation
general and...
$2,719,674
(-11.17%↓ Y/Y)
Back